Projects funded by the NCN
Galactosylceramide as a regulator of apoptotic gene expression and modulator of drug resistance in breast cancer cells.
2019/35/B/NZ5/01392
Keywords:
breast cancer galactosylceramide apoptosis drug resistance,
Descriptors:
- NZ5_1: Etiology of human diseases
- NZ5_7: Human disease treatment
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Przyrodniczy we Wrocławiu, Wydział Medycyny Weterynaryjnej
woj. dolnośląskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 4
Call: OPUS 18 - announced on 2019-09-16
Amount awarded: 1 560 895 PLN
Project start date (Y-m-d): 2020-07-02
Project end date (Y-m-d): 2023-07-01
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.